Search

Issue
Title
Authors
Avastin in clinical chemotherapy of malignant tumors
Gorbunova V.A.
HPV-associated lesions in the Russian Federation: assessment of the problem
Briko N.I., Lopukhov P.D., Kaprin A.D., Novikova E.G., Trushina O.I., Khaldin A.A., Isaeva D.R., Skvortsova A.I.
Renal cell carcinoma associated with von Hippel–Lindau syndrome: an ambispective study
Volkova M.I., Turupaev K.A., Filippova M.G., Ladyko D.D., Sinitsyna O.R., Gridneva Y.V., Matveev V.B.
First results of a multicenter, non-randomized, prospective phase II study of the efficacy and safety of induction therapy with pembrolizumab, cisplatin, and 5-fluorouracil in patients with unresectable squamous cell carcinoma of the oropharynx, hypopharynx and larynx
Stativko O.A., Pokataev I.A., Kravtsov S.A., Zhukova L.G., Stroyakovskiy D.L., Sabitov E.R., Kuzmina E.S., Feoktistova P.S., Antonova T.G., Lyadova M.A., Nosova M.V., Sydykova R.S., Lisitsyna K.N., Strelnikova T.B., Alizade G.R., Parts S.A., Dolov M.M., Tedeeva A.K., Galkin V.N.
Basal cell skin carcinoma: Epidemiology of locally advanced and metastatic forms based on the data of the N.N. Blokhin National Medical Research Center of Oncology: A retrospective study
Orlova K.V., Martynova M.V., Petenko N.N., Nazarova V.V., Demidov L.V.
Laparoscopic pelvic exenteration for malignant tumors of the female reproductive system: a case series
Lyadov V.K., Nevrov A.S., Garipov M.R., Moskalenko A.N., Simbiryov T.V., Galkin V.N.
A clinical case of treatment of recurrent inoperable locally advanced breast cancer using conformal radiotherapy. Case report
Medvedev S.V., Vlasova M.Y., Bolotina L.V., Kaprin A.D., Khmelevskiy E.V., Zikiryakhodzhaev A.D., Khakimova S.G., Khakimova G.G., Bychkova N.M., Zaitseva N.A., Abushova E.R., Guseva S.D., Maslov E.D.
Following in the footsteps of SABCS 2022: top 16 early breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Diagnosis of renal cell carcinoma in patients with prostate cancer: capabilities of PET/CT with 18F-PSMA-1007
Ognerubov N.A., Mirsalimova O.O., Antipova T.S.
The ability to combine autodermoplasty in the treatment of patients with malignant tumors of the skin extremities (clinical observation)
Vaschenko L.N., Dashkova I.R., Kechedzhieva E.E., Babieva S.M.
New therapies for hormone-positive HER2-negative metastatic breast cancer with AKT signaling alterations: the Expert Panel Decision
Editorial B.
Disability-Adjusted Life Year (DALY) assessment and economic damage from premature death of cervical uterine and ovarian cancers in the Tomsk Region
Zhuikova L.D., Ananina O.A., Sirotina A.S., Pikalova L.V., Fokin V.A., Kononova G.A.
Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Alexandrova E.G.
Characteristics of the receptor phenotype of tumor-associated immune cells of the epithelial-mesenchymal microenvironment of ovarian cancer
Zhurman V.N.
PARP (Poly ADP‐Ribose Polymerase) inhibitors for locally advanced or metastatic breast cancer (Russian Translation of Cochrane Plain Language Summary)
Uvarova K.G.
Experience in the treatment of radioinduced angiosarcoma of the breast in a patient with primary multiple lesions of the breast and bladder. Case report
Semenov E.V., Gasymly D.D., Zyuzyukina A.V., Zukov R.A.
Second primary cancer in patients with head and neck squamous cell carcinoma: case report
Agabekyan G.O., Stelmakh D.K., Aydarbekova A.A.
The role of targeted therapy in the treatment of advanced hepatocellular carcinoma
Shakhnovich E.B., Kerbikov O.B., Kulaga E.A.
Mesto tsetuksimaba v terapii metastaticheskogo raka tolstoy kishki
Artamonova E.V.
Preclinical studies of cytotoxicity and cytostatic activity of five new imidazotriazine derivatives in MDA-MB231, BT474, and MCF-7 breast cancer cell cultures
Al-Humairi A.H., Buldakov M.A., Novochadov V.V., Cherdyntseva N.V., Udut V.V.
Clinical factors of the risk of hyperplastic endometry processes on tamoxifen therapy with breast cancer: Retrospective population study
Golubenko E.O., Savelyeva M.I., Poddubnaya I.V., Korennaya V.V.
PARP inhibitors in female reproductive system cancers
Pokataev I.A., Tyulyandin S.A.
Efficacy and safety of pemetrexed maintenance therapy in advanced non-small-cell lung cancer: a review of phase III studies
Kit O.I., Vladimirova L.Y., Sholokhova E.A.
Denosumab (AMG-162) v profilaktike osteoporoza, vyzvannogo priemom ingibitorov aromatazy u bol'nykh rakom molochnoy zhelezy v ad\"yuvantnoy terapii i u bol'nykh rakom predstatel'noy zhelezy pri polnoy androgennoy blokade
Lichinitser M.R., Semenov N.N.
Neksavar® (sorafenib)v lechenii rasprostranennogo pochechno-kletochnogo raka
Podregul'skiy K.E.
Estramustina fosfat (estratsit) v lechenii raka predstatel'noy zhelezy (po materialam Journal of Clinical Oncology, 2005 ASCO Proceedings)
Podregul'skiy K.E.
Role of repeat biopsies of metastatic and recurrent lesions for the study of tumor heterogeneity in luminal breast cancer: Retrospective and prospective analyses
Gluzman M.I., Chistyakova E.A., Raskin G.A., Orlova R.V.
The combination of lenvatinib and pembrolizumab in the treatment of patients with metastatic kidney cancer and factors of poor prognosis: experience of clinics in Moscow: A prospective observational study
Pokataev I.A., Stroyakovskiy D.L., Fedyanin M.Y., Zhukova L.G., Stativko O.A., Andreyashkina I.I., Volkova M.I., Volkonskiy M.V., Polshina N.I., Kotova E.V., Kravchuk D.A., Bystrov A.A., Antonova T.G., Lyadova M.A., Kuzmina E.S., Parts S.A., Salpagarov M.K., Galkin V.N., Klimov A.V.
Endoscopic criteria for early differential diagnosis of gastritis-like form of primary non-Hodgkin's lymphomas and gastric cancer: A prospective study
Lozovaia V.V., Malikhova O.A., Tumanyan A.O., Gusarova O.A.
Rare histological subtypes of bladder cancer in clinical practice: a case series
Paychadze A.A., Golubeva S.A., Kamalova M.A.
Diagnostic potential of endosonography in primary and secondary esophageal tumors: retrospective study
Khalaev Z.V., Suleymanov E.A., Malikhova O.A., Tumanyan A.O., Krylovetskaia M.A., Kontsevaya A.Y., Salimova A.A., Makarova M.V.
The era of immuno-oncology in onco-urology: what have we achieved? The review of the symposium of the alliance between Merck and Pfizer held within the framework of the XXV Russian Oncology Congress. November 9, 2021
Editorial B.
Cabazitaxel in the treatment of metastatic castration-resistant prostate cancer
Ognerubov N.A.
Squamous cell breast cancer: description of a rare clinical case
Zikiryakhodjaev A.D., Khakimova S.G., Rasskazova E.A., Saribekian E.K., Omarova D.F., Surkova V.S., Khakimova G.G.
Adenosquamous carcinoma of the colon: case report
Nefedova N.A., Kharlova O.A., Malkov P.G., Kharlov N.S., Danilova N.V.
Fraksiparin kak osnovnoe sredstvo profilaktiki tromboembolii legochnoy arterii v posleoperatsionnom periode u bol'nykh kolorektal'nym rakom
Makarov O.G.
Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer
Saevets V.V., Kuzmin N.K., Ponomareva N.A., Krashikhina T.V., Mochalova A.S., Vasilyev L.A., Stroyakovsky D.L., Kolomiets L.A., Averyanova S.V., Yavorskaya M.A., Orlova S.A., Boskhomjieva M.V., Peganova E.V., Shalina A.I., Kosukhina A.A., Khaikin A.M., Shkradyuk A.V., Bobrova E.A., Dikhtyar T.N., Shikina V.E., Sultanbaev A.V., Kudryavtsev I.Y., Zinkina-Orikhan A.V., Fogt S.N., Kiseleva P.V., Svechnikov E.V.
Cardiovascular toxicity of chemotherapy and thyroid status of patients with gastric and colon cancer: Current state of the problem. A review
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polianskii M.B., Pis'mennaia E.V.
Benefits and limitations of breastfeeding for mothers with malignant tumors
Ladodo O.B., Iurova M.V., Khokhlova S.V., Rodionov V.V., Sheshko E.L., Zubkov V.V., Makieva M.I., Chutkova D.A., Akhapkina E.S., Degtyarev D.N.
Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study
Evdokimov V.I., Bloshchinenko A.A., Abolmasov A.E., Vilensky A.A., Laskov M.S.
Following in the footsteps of SABCS 2022: top 12 advanced breast cancer studies that could change our clinical practice: A review
Kolyadina I.V.
Cabozantinib in the treatment of patients with advanced renal cell carcinoma
Volkova M.I., Turupaev K.A., Kalinin S.A.
Modern ultrasound technologies in monitoring the effectiveness of chemotherapy for cervical cancer
Musaeva Z.R., Chekalova M.A., Mesheryakov A.A.
The potential use of oncolytic viruses in breast cancer: historical aspects and future prospects (literature review)
Morozov D.A., Kolyadina I.V., Poddubnaya I.V., Chumakov P.M., Ilinskaya G.V., Bokhian V.Y., Sopova M.I.
Clinical cases of treatment of hepatocellular carcinoma
Lazarev S.A., Mamontov K.G., Manihas G.M., Antimonik N.Y.
Lechenie metastazov kolorektal'nogo raka v pecheni
Patyutko Y.I., Sagaydak I.V., Pylev A.L., Podluzhnyy A.N., Chuchuev E.S., Shishkina N.A.
Primenenie tsetuksimaba v lechenii ploskokletochnogo raka golovy i shei
Romanov I.S., Kupchan D.Z.
Prognostic significance of primary and interval cytoreductive surgery in late-stage ovarian cancer. A retrospective study
Zhurman V.N., Nechushkina V.M., Maslennikova A.V.
Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study
Sokolova T.N., Solov'eva T.I., Aleksakhina S.N., Janus G.A., Goryainova A., Gluzman M.I., Orlova R.V., Stukan A.I., Zukov R.A., Zyuzyukina A.V., Murunova Y.N., Sultanbaev A.V., Vorobeva E.N., Mikhaevich L.M., Pyliv V.N., Lysenko A.N., Khachmamuk Z.K., Kozlov A.E., Bakharev S.Y., Parsyan S.G., Rossokha E.I., Osidze L.D., Shumskaya I.S., Agaeva A.V., Kasmynina T.A., Klimenko V.V., Akhmetgareeva K.T., Vakhitova A.A., Chakhkieva M.D., Dmitriev V.N., Bakshun Y.I., Vasilyev A.E., Gasimly D.D., Kravchenko N.A., Maksimov D.A., Nesterova A.I., Sharvashidze I.O., Gadzaova C.H., Rakhmankulova G.G., Khamgokov Z.M., Amirkhanova I.K., Bembeeva L.V., Vladimirov V.I., Petrenko O. ., Ruskova N.G., Serikova E.L., Subbotina K.S., Tkachenko S.A., Chang V.L., Erdniev S.P., Barbara V.S., Vasilevskaya A.V., Mikheeva Y.V., Popova N.O., Startseva E.P., Fateeva A.V., Yukalchuk D.Y., Grechkina A.A., Musaeva K.S., Odintsova S.V., Stel'makh A.S., Khabibulaeva P.I., Khlobystina A.G., Shvaiko K.A., Basova E.A., Bogomolova I.A., Bolieva M.B., Goldberg V.E., Kibisheva M.V., Menshikov K.V., Ryazanov D.V., Stepanova M.L., Udalova Y.A., Shkradyuk A.V., Chapko Y.S., Shchukina A.A., Khabriev I.M., Kirtbaya D.V., Degtyarev A.M., Epkhiev A.A., Tyugina Y.A., Murachuev M.A., Togo A.V., Ievleva A.G., Imyanitov E.N.
Osimertinib for the first-line treatment of EGFR-positive non-small cell lung cancer
Reutova E.V., Laktionov K.P., Iudin D.I., Neliubina L.A., Gorokhova G.K., Egorova A.V.
Anxiety and cognitive impairment in elderly patients with gastrointestinal cancers
Stilidi I.S., Kotyukova A.Y., Lyadov V.K.
Passive smoking prevalence among patients of krasnoyarsk regional oncologic dispensary
Kutumova O.Y., Kononova L.I., Dobretsova E.A., Shulmin A.B., Korotkova K.M., Rossiyeva T.V.
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib
Sheko S.S., Dem'yanova G.A.
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy
Results of lenvatinib as first-line targeted therapy for advanced hepatocellular cancer: a retrospective study
Antonova E.Y., Janyan I.A., Laktionov K.K., Pogrebnyakov I.V., Savchenko I.V., Breder V.V.
The molecular basis of thyroid status formation and its role in the initiation and promotion of gastric and colorectal cancer: A review
Stanoevich I.V., Ioutsi V.A., Lysovolenko N.L., Alekseev I.E., Kondrashkina A.D., Polyansky M.B., Pis'mennaia E.V.
Membrane (CD8⁺PD-1⁺ and CD4+PD-1⁺) and soluble (sPD-1 and sPD-L1) forms of immune checkpoints in melanoma, breast cancer, and oral mucosal cancer patients: A observational study
Zabotina T.N., Chertkova A.I., Borunova A.A., Kushlinskii N.E., Gershtein E.S., Zakharova E.N., Shoua E.K., Tsiklauri V.T., Samoylenko I.V., Khoroshilov M.V., Kadagidze Z.G.
Place of durvalumab in the treatment of biliary tract cancer: A review
Breder V.V., Ledin E.V., Chubenko V.A., Orlova R.V., Petkau V.V., Pokataev I.A.
Place of CDK 4/6 and PARP inhibitors in the modern treatment approach of HER2-negative breast cancer
Editorial B.
Clinical prognostic factors of bilateral synchronous renal cancer
Komarov M.I., Matveev V.B., Volkova M.I., Komarov I.G., Ridin V.A.
Regorafenib: from clinical research to clinical practice
Fedyanin M.Y., Tryakin A.A.
Current algorhytm of screening and early diagnosis of hepatocellular carcinoma
Tikhonov I.N., Pavlov C.S., Mayevskaya M.V., Ivashkin V.T.
Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer
Laktionov K.K., Fedyanin M., Stroyakovskiy D.L., Mochalova A.S., Iasieva A.R., Fadeeva N.V., Shapovalova I.S., Mironov O.V., Dergunov A.S., Orlov S.V., Vasilev L.A., Bobrova E.A., Orlova S.A., Kosukhina A.A., Polshina N.I., Vardanian S.G., Fedoseev A.I., Tumasian K.S., Danilova A.E., Krashikhina T.V., Tsygankova E.I., Staritsyn D.E., Toporkova O.V., Boskhomdzhieva M.V., Sultanbaev A.V., Edamenko M.V., Dmitriev V.N., Shkradiuk A.V., Shkret K.A., Prosianikova O.N., Svechnikov E.V., Grigorchuk S.Y.
Determination of sentinel lymph nodes in gynecological cancer using the radiopharmaceutical Sentiscan. A case series
Shevchuk A.S., Krylov A.S., Knyazev R.I., Afanasieva K.V.
Which faecal blood test is more accurate in detecting bowel cancer and large polyps in population screening? (Russian Translation of Cochrane Plain Language Summary (PLS))
Plyakhina K.S.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K.K., Artamonova E.V., Borisova T.N., Breder V.V., Bychkov I.M., Vladimirova L.I., Volkov N.M., Ergnian S.M., Zhabina A.S., Kononets P.V., Kuz’minov A.E., Levchenko E.V., Malikhova O.A., Marinov D.T., Miller S.V., Moiseenko F.V., Mochal’nikova V.V., Novikov S.N., Pikin O.V., Reutova E.V., Rodionov E.O., Sakaeva D.D., Semenova A.I., Smolin A.V., Sotnikov V.M., Tuzikov S.A., Turkin I.N., Tiurin I.E., Chkhikvadze V.D., Kolbanov K.I., Chernichenko A.V., Fedenko A.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil’mutdinova I.R., Gridneva I.V., Eremushkin M.A., Zernova M.A., Kasparov B.S., Kovlen D.V., Kondrat’eva K.O., Konchugova T.V., Korotkova S.B., Krutov A.A., Obukhova O.A., Ponomarenko G.N., Semiglazova T.I., Stepanova A.M., Tkachenko G.A., Khulamkhanova M.M.
Supportive therapy for ovarian cancer
Pokataev I.A., Tyulyandin S.A.
A population-based portrait of breast cancer in russia: a cancer register-based analysis in russian
Poddubnaya I.V., Kolyadina I.V., Kalashnikov N.D., Borisov D.A., Makarova M.V.
Targetnaya terapiya rasprostranennogo raka pochki: problema vybora preparata na primere mul'tikinaznykh ingibitorov
Matveev V.B.
Tsetuksimab pri lechenii metastaticheskogo kolorektal'nogo raka
Sekacheva M.I., Skipenko O.G.
Experience with olaparib in the treatment of BRCA-associated tumors in real clinical practice. Observational study
Sultanbaev A.V., Menshikov K.V., Musin S.I., Nasretdinov A.F., Fatikhova A.A., Izmailov A.A., Lipatov O.N., Ayupov R.T., Sultanbaeva N.I., Menshikova I.A., Serebrennikov G.A.
The role of bevacizumab in the treatment of patients with ovarian and cervical cancer
Khokhlova S.V.
Novel therapies for the metastatic HER2-positive breast cancer with metastases in the central nervous system: a clinical case
Radyukova I.M., Rats N.M.
Comparison of the efficacy of neoadjuvant chemotherapy with FLOT regimen and adjuvant chemotherapy with XELOX/FOLFOX regimen in patients with locally advanced gastric cancer: A retrospective study
Semenov N.N., Izrailov R.E., Semenov N.E., Zhukova L.G., Feoktistova P.S., Matveychuk D.A., Khatkov I.E.
Malignant neoplasm of the bronchi and lung: Russian clinical guidelines
Laktionov K.K., Artamonova E.V., Borisova T.N., Breder V.V., Bychkov I.M., Vladimirova L.I., Volkov N.M., Ergnian S.M., Zhabina A.S., Kononets P.V., Kuzminov A.E., Levchenko E.V., Malikhova O.A., Marinov D.T., Miller S.V., Moiseenko F.V., Mochal’nikova V.V., Novikov S.N., Pikin O.V., Reutova E.V., Rodionov E.O., Sakaeva D.D., Sarantseva K.A., Semenova A.I., Smolin A.V., Sotnikov V.M., Tuzikov S.A., Turkin I.N., Tyurin I.E., Chkhikvadze V.D., Kolbanov K.I., Chernykh M.V., Chernichenko A.V., Fedenko A.A., Filonenko E.V., Nevol’skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil’mutdinova I.R., Gridneva I.V., Eremushkin M.A., Zernova M.A., Kasparov B.S., Kovlen D.V., Kondrat’eva K.O., Konchugova T.V., Korotkova S.B., Krutov A.A., Obukhova O.A., Ponomarenko G.N., Semiglazova T.I., Stepanova A.M., Khulamkhanova M.M.
Dual immunological blockade in the treatment of metastatic non-small cell lung cancer: reality and perspectives
Yudin D.I., Laktionov K.K., Laktionova L.V., Breder V.V.
The first results of the national programme for the diagnosis and treatment of HER2-positive breast cancer in Turkmenistan
Berdimyradova M.B., Khadjiev S.M., Khommadova D.N., Polatova G.O., Kakajanova A.O., Batyrov C.B., Penayev D.N., Agayeva B.G., Annaberdiyeva G.A.
Ramucirumab therapy in patients with advanced gastric cancer: discussion of a case series
Orlova R.V., Zhukova L.G., Ganshina I.P., Yukalchuk D.Y., Ponomarenko D.M., Beliak N.P., Gordeeva O.O., Erdniev S.P., Minasyan A.A., Dashkova A.A., Sopiya E.R., Sholokhova E.A., Gurochkin A.B.
Hyperthermia is an additional option in the treatment of squamous cell cancer of the anal canal
Glebovskaya V.V., Tkachev S.I., Ivanov S.M., Nazarenko A.V., Rasulov A.O., Gordeev S.S., Bulychkin P.V., Besova N.S., Barsukov U.A., Trofimova O.P., Borisova T.N., Timoshkina E.V.
Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary?
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
The characteristics of determination of BRCA1 and BRCA2 mutations in serous ovarian cancer
Demidova I.A.
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
Khokhlova S.V.
Concerning selective neck dissections in oral squamous cell carcinoma
Alymov Y.V., Podvyaznikov S.O., Mudunov A.M.
Efficacy of cisplatin-based combinations in chemoradiation therapy of cervical cancer
Bazaeva I.Y., Gorbounova V.A., Kravets O.A., Khokhlova S.V., Romanova E.A.
Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
Semiglazova T.Y., Dashyan G.A., Semiglazov V.V., Zhabina A.S., Osipov M.A., Kotova Z.S., Klimenko V.V., Krivorotko P.V., Semiglazov V.F.
Male breast cancer: review of the literature
Nikolaev K.S., Semiglazov V.F., Semiglazov V.V.
HER2-positive disseminated gastric and gastro-oesophageal junction adenocarcinoma: forecast, clinical course, treatment
Besova N.S.
The results of Epidemiological HER2 screening program in patients with breast cancer in 2013
Frank G.A., Poddubnaya I.V., Yagudina R.I., Borisov D.A., Koroleva N.I.
Clinical example of the drug pazopanib as a targeted therapy in inoperable cancer of the kidney
Klimenko A.A., Ivanov S.A.
Retseptor faktora rosta fibroblastov 1-go tipa kak mishen' tselenapravlennoy terapii pochechno-kletochnogo raka
Timofeev I.V.
Surgical stading local – cervical cancer incidence
Kargopolova M.V., Maximov S.Y., Berlev I.V., Boyarkina M.P., Meshkova I.E., Khadzhimba A.S., Novikov S.N., Krzhivitsky P.I., Ponomareva O.I., Urmancheeva A.F., Ivanzov A.O., Guseynov K.D., Vishinskaya E.A., Matveeva N.S.
Diagram of differential diagnostics of stages of ovarian cancer
Antoneeva I.I., Abakumova T.V., Gening T.P., Gening S.O.
Press-reliz V Tomske otkrylsya Tsentr ranney diagnostiki opukholey pecheni
Sravnitel'noe issledovanie opredeleniya HER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
Samoe masshtabnoe sravnitel'noe issledovanie III fazy iz vsekh ranee opublikovannykh pokazalo, chto IRESSATM (gefitinib) tak zhe effektivna, kak i dotsetaksel u patsientov s rasprostranennym nemelkokletochnym rakom legkogo posle neudachi predshestvuyushchey terapii
Ad\"yuvantnoe lechenie raka tolstoy kishki
Artamonova E.V., Podregul'skiy K.E.
Postmastektomicheskaya limfedema verkhnikh konechnostey: vozmozhnosti konservativnogo lecheniya
Myasnikova M.O.
Mesto UZT pri planirovanii lecheniya zlokachestvennykh epitelial'nykh opukholey yaichnikov
Chekalova M.A., Poddubnaya I.V., Mazyrko M.A., Sinitsina M.E.
Prognosticheskie faktory effektivnosti lecheniya retsidiva raka yaichnikov IV stadii
Mel'ko A.I., Ushakov I.I., Kira E.F., Shamkina V.O., Gaytukieva R.A.
Opyt profilakticheskogo primeneniya rekombinantnogo faktora Vila dlya umen'sheniya intraoperatsionnykh krovotecheniy u onkologicheskikh bol'nykh
Barkagan Z.S., Khodorenko S.A., Mamaev A.N., Nazarov A.V., Mamaeva I.V., Tsyvkina L.P., Rossokha A.V.
Sostoyanie zabolevaemosti, smertnosti i onkologicheskoy pomoshchi pri zlokachestvennykh novoobrazovaniyakh kozhi v Navoiyskoy oblasti Respubliki Uzbekistan
Kudryavtsev I.Y., Aksel' E.M., Kerimov R.A.
Endoskopicheskaya semiotika i diagnostika limfom glotochnogo kol'tsa Pirogova-Val'deyera
Belousova N.V., Poddubnyy B.K., Ungiadze G.V., Arkhipov V.V., Gubin A.N.
Odnomomentnoe udalenie dvukh metastazov raka legkogo iz raznykh oblastey golovnogo mozga
Karakhan V.B., Aleshin V.A., Fu R.G., Krat V.B.
Evolution of anti-HER2 therapy in advanced HER2+ breast cancer or “why is trastuzumab still a key player?”. A review
Grechukhina K.S., Sukhova M.V., Kolyago E.M., Filonenko D.A., Zhukova L.G.
Analysis of the survival rate of patients with ovarian cancer of stages I–IV: A retrospective study
Zhurman V.N.
Comparative analysis of efficacy and safety of combined immunotherapy and immune targeted therapy in the first-line treatment of advanced renal cell carcinoma: a real-world study
Pokataev I.A., Stativko O.A., Volkova M.I., Fedorova A.N., Zueva E.V., Ibragimova M.R., Tsareva E.V., Antonova T.G., Sinitsyna O.R., Cherniaev V.A., Gridneva Y.V., Oskarev A.V., Galkin V.N.
Isolated metastasis to the scalp in occult breast cancer: a clinical case
Ognerubov N.A., Sergeev R.S., Hizhnyak A.O., Ognerubova M.A., Dzhabrailov M.A.
Correction of lower limb lymphedema in patients with cervical cancer after combination treatment: A case report
Obukhova O.A., Dibirova P.A., Kurmukov I.A., Allakhverdiyan G.S., Shagina N.Y., Mustafina E.А., Knyazev R.I., Pajanidi J.G.
Solitary metastasis of colorectal cancer in the left adrenal gland 4 years after surgery on the primary tumor. Case report
Budurova M.D., Trifanov V.S., Kopylov V.V., Kuznetsova O.S., Chernichenko M.A., Poluektov S.I.
Experience in organizing nutritional support in cancer patients at the Tsyb Medical Radiological Research Centre
Potapov A.L., Аgababyan T.A., Dorozhkin A.D., Pimonova I.S., Nevolskikh A.A., Ivanov S.A., Kaprin A.D.
The role of neoadjuvant chemotherapy in patients with primary resectable pancreatic cancer: A retrospective cohort study
Khatkov I.E., Semenov N.N., Izrailov R.E., Efanov M.G., Dalgatov K.D., Zhukova L.G.
Clinical case of complications of immunotherapy – encephalitis
Lyadova M.A., Kuchevskaya O.A., Kulikova E.A.
Antitumor response and quality of life: is there a need to sacrifice? Clinical observation: long-term and safe control of the disease using a combination of ribociclib with letrozole. Case report
Grechukhina K.S., Vorontsova K.A., Filonenko D.A., Tyutyunnik P.S., Shchadrova V.V., Zhukova L.G.
Malignant refractory priapism in case of urothelial cancer. Case report
Ognerubov N.A., Antipova T.S.
Osimertinib and routine practice: the experience of the drug application in different clinical situations in case of metastatic non-small cell lung cancer with an EGFR mutation. Case report
Orlov S.V., Baldin P.L., Diuzeva N.V., Krechetova A.V., Mordovskiy A.A., Moskovchenko A.N., Musaeva N.E., Romanchuk O.V.
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
Gastric cancer: Russian clinical guidelines
Besova N.S., Kalinin A.E., Nered S.N., Triakin A.A., Gamaiunov S.V., Kozlov N.A., Stilidi I.S., Karachun A.M., Kononets P.V., Malikhova O.A., Riabov A.B., Khomiakov V.M., Fedenko A.A., Bolotina L.V., Falaleeva N.A., Nevol'skikh A.A., Ivanov S.A., Khailova Z.V., Gevorkian T.G., Butenko A.V., Gil'mutdinova I.R., Eremushkin M.A., Ivanova G.E., Kondrat'eva K.O., Konchugova T.V., Krutov A.A., Obukhova O.A., Semiglazova T.I., Filonenko E.V., Khulamkhanova M.M., Romanov A.I.
Regorafenib in metastatic colorectal cancer: more data for clinical decisions
Petkau V.V., Karimova A.A., Akishina Z.V.
Anti-anemia drugs shorten survival for some cancer patients (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.U.
Refractory metastatic colorectal cancer: challenges and solutions during the COVID-19 pandemic
Sekacheva M.I., Fatyanova A.S., Meretukov D.A., Zhilenkova A.V., Rusanov A.S., Rozhkov A.A., Guryanova A.A., Bagmet N.N.
Actual treatment options for locally advanced and metastatic cutaneous squamous cell carcinoma
Ignatova A.V.
Can any breast skin thickening be staged as T4?
Amosova V.A., Petrovskii A.V., Karpova M.S., Ponedel’nikova N.V., Frolova M.A.
The consensus on the prevention and correction of hyperglycemia in patients with HR+ HER2- metastatic breast cancer treated with alpelisib
Mazurina N.V., Artamonova E.V., Beloyartseva M.F., Volkova E.I., Ganshina I.P., Troshina E.A., Tjulandin S.A., Chubenko V.A.
Lenvatinib as the key component of first-line therapy for patients with unresectable hepatocellular carcinoma
Bolotina L.V.
Opportunities for metastatic triple negative breast cancer therapy
Ganshina I.P., Gordeeva O.O., Manukyan M.S.
Modern view on the issues of diagnosis and verification of axillary lymph nodes involvement in early breast cancer
Kolyadina I.V., Danzanova T.Y., Khokhlova S.V., Trofimova O.P., Kovaleva E.V., Rodionov V.V., Poddubnaya I.V.
The use of regorafenib in colorectal cancer
Sekacheva M.I., Bagmet N.N., Guryanova A.A., Rashi D.A.
Unresectable hepatocellular carcinoma: new opportunities and prospects for therapy
Abdurakhmanov D.T., Breder V.V., Bolotina L.V., Kosyrev V.I., Medvedeva B.M., Petkau V.V.
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I.V., Poddubnaya I.V.
Ribociclib in 1st line HR+ breast cancer treatment
Zhukova L.G., Ganshina I.P., Gordeeva O.O., Lubennikova E.V.
Clinical cases of the treatment of metastatic colorectal cancer in Russia
Goldberg V.E., Hasanova A.I., Shkuratova V.V., Belevich Y.V., Popova N.O., Simolina E.I., Vysockaya V.V., Dudnikova E.A., Kravchuk T.L., Minnabetdinova R.R., Nekrasova O.V.
Using of multi-kinase inhibitor regorafenib for metastatic colorectal cancer
Kit O.I., Vladimirova L.Y., Abramova N.A., Storozhakova A.E., Popova I.L., Tikhanovskaya N.M., Lyaynova A.A., Ryadinskaya L.A.
Predictive factors of achievement pathological complete response at neoadjuvant chemotherapy of primary operable breast cancer
Pavlikova O.A., Kolyadina I.V., Komov D.V., Vishnevskaya Y.V., Poddubnaya I.V.
Surgical treatment and clinicopathological characteristics of patients with neuroendocrine neoplasms of the stomach
Bokhyan V.Y., Peregorodiev I.N., Delektorskaya V.V., Arkhiri P.P., Stilidi I.S.
Cost-effectiveness of empegfilgrastim (Extimia®) for the prevention of severe neutropenia in patients with malignant neoplasm of female breast
Rudakova A.V., Tolkacheva D.G., Gavrilova O.N., Vaganov A.S.
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
Latent herpes virus infection in the carcinogenesis of bladder cancer
Loran O.B., Sinyakova L.A., Gundorova L.V., Kosov V.A., Kosova I.V., Kolbasov D.N., Kononkov I.V.
Comparative evaluation of the efficacy of an incomplete cytoreduction application in combination with systemic therapy and systemic therapy as mono-therapy in patients with metastatic clear-cell renal cell carcinomas
Borisov P.S., Orlova R.V., Shkolnik M.I., Karlov P.A.
The use of combined plastic interventions in the reconstruction of post-operative soft tissue defects of the chest wall in the surgical treatment of locally advanced breast cancer
Vashenko L.N., Daschkova I.R., Bakulina S.M., Andreyko E.A.
Clinical case long-term care of the patient with mCRPC
Zaborskiy I.N., Karjakin O.B.
Pharmacoeconomic usefulness of the drug Giotrif® (afatinib) in first-line treatment of locally advanced or metastatic non-small cell lung cancer with a mutation of epidermal growth factor receptor (EGFR)
Kolbin A.S., Kurylev A.A., Pavlysh A.V., Proskurin M.A., Balykina Y.Y.
Modern possibilities of HER2 positive breast cancer treatment (based on clinical trials)
Kolyadina I.V., Poddubnaya I.V.
Difficulties in treating patients with breast cancer in Russia: the resolution on the results of the Review Board
Artamonova E.V., Gorbunova V.A., Zhukov N.V., Manzjuk L.V., Manihas A.G., Paltuev P.M., Semiglazov V.F., Semiglazova T.Y., Stenina M.B., Tjuljandin S.A., Chubenko V.A.
Selection of the anti-angiogenesis therapy for the first-line chemotherapy in advanced ovarian cancer
Khokhlova S.V.
The efficiency of trabectedin in the monotherapy and combinations in the treatment of advanced ovarian cancer
Cherkasova M.V., Khokhlova S.V., Limareva S.V., Bazaeva I.Y., Orel N.F., Gorbunova V.A., Poddubnaya I.V.
Antiangiogennaya terapiya disseminirovannogo kolorektal'nogo raka
Meshcheryakov A.A.
Press-reliz44-e ezhegodnoe zasedanie Evropeyskoy assotsiatsii po izucheniyu pecheni (EASL)
Press-reliz Novaya era v lechenii raka pochki
Effektivnost' ad\"yuvantnoy terapii anastrozolom i tamoksifenom u patsientok s rannimi stadiyami raka molochnoy zhelezy (analiz dannykh issledovaniya ATAC pri mediane vremeni nablyudeniya 100 mes)
Sravnitel'noe issledovanie opredeleniya NER2-statusa raka molochnoy zhelezy metodami immunogistokhimii i in situ gibridizatsii
Zavalishina L.E., Andreeva Y.Y., Ryazantseva A.A., Bateva M.V., Frank G.A.
1 - 150 of 484 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

Согласие на обработку персональных данных с помощью сервиса «Яндекс.Метрика»

1. Я (далее – «Пользователь» или «Субъект персональных данных»), осуществляя использование сайта https://journals.rcsi.science/ (далее – «Сайт»), подтверждая свою полную дееспособность даю согласие на обработку персональных данных с использованием средств автоматизации Оператору - федеральному государственному бюджетному учреждению «Российский центр научной информации» (РЦНИ), далее – «Оператор», расположенному по адресу: 119991, г. Москва, Ленинский просп., д.32А, со следующими условиями.

2. Категории обрабатываемых данных: файлы «cookies» (куки-файлы). Файлы «cookie» – это небольшой текстовый файл, который веб-сервер может хранить в браузере Пользователя. Данные файлы веб-сервер загружает на устройство Пользователя при посещении им Сайта. При каждом следующем посещении Пользователем Сайта «cookie» файлы отправляются на Сайт Оператора. Данные файлы позволяют Сайту распознавать устройство Пользователя. Содержимое такого файла может как относиться, так и не относиться к персональным данным, в зависимости от того, содержит ли такой файл персональные данные или содержит обезличенные технические данные.

3. Цель обработки персональных данных: анализ пользовательской активности с помощью сервиса «Яндекс.Метрика».

4. Категории субъектов персональных данных: все Пользователи Сайта, которые дали согласие на обработку файлов «cookie».

5. Способы обработки: сбор, запись, систематизация, накопление, хранение, уточнение (обновление, изменение), извлечение, использование, передача (доступ, предоставление), блокирование, удаление, уничтожение персональных данных.

6. Срок обработки и хранения: до получения от Субъекта персональных данных требования о прекращении обработки/отзыва согласия.

7. Способ отзыва: заявление об отзыве в письменном виде путём его направления на адрес электронной почты Оператора: info@rcsi.science или путем письменного обращения по юридическому адресу: 119991, г. Москва, Ленинский просп., д.32А

8. Субъект персональных данных вправе запретить своему оборудованию прием этих данных или ограничить прием этих данных. При отказе от получения таких данных или при ограничении приема данных некоторые функции Сайта могут работать некорректно. Субъект персональных данных обязуется сам настроить свое оборудование таким способом, чтобы оно обеспечивало адекватный его желаниям режим работы и уровень защиты данных файлов «cookie», Оператор не предоставляет технологических и правовых консультаций на темы подобного характера.

9. Порядок уничтожения персональных данных при достижении цели их обработки или при наступлении иных законных оснований определяется Оператором в соответствии с законодательством Российской Федерации.

10. Я согласен/согласна квалифицировать в качестве своей простой электронной подписи под настоящим Согласием и под Политикой обработки персональных данных выполнение мною следующего действия на сайте: https://journals.rcsi.science/ нажатие мною на интерфейсе с текстом: «Сайт использует сервис «Яндекс.Метрика» (который использует файлы «cookie») на элемент с текстом «Принять и продолжить».